mRNA-1365

N/A

Report date: 2026/05/12 09:10:13

Base Information

Drug NamemRNA-1365

Drug Alias NamePediatric RSV + hMPV vaccine (Moderna Therapeutics)mRNA-1365

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionRespiratory syncytial virus F protein inhibitors

TargetsRespiratory syncytial virus F protein

Therapy Area/IndicationsRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesModerna Inc

Active IndicationsN/A

Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeN/A